Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Usui

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Clinics (Sao Paulo, Brazil)|November 14, 2025
Effects of pemafibrate (a selective PPAR-α agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLDKanako Kato, Teruo Jojima, Dai Tanuma, et al.
Journal of Diabetes and Its Complications|February 19, 2021
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosisMasaaki Sagara, Toshie Iijima, Masato Kase, et al.
International Journal of Clinical Practice|August 13, 2021
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitorsToshie Iijima, Soichiro Hosonuma, Hidetaka Kurai, et al.
Diabetology International|August 5, 2024
Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetesTomohisa Kunii, Isao Usui, Teruo Jojima, et al.
Journal of Medical Case Reports|April 21, 2019
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case reportTomohisa Kunii, Toshie Iijima, Teruo Jojima, et al.
Endocrine Journal|March 7, 2022
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intoleranceTeruo Jojima, Toshimitsu Shinzawa, Eriko Ohira, et al.
Biochemical and Biophysical Research Communications|January 2, 2010
Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver diseaseWei Zhang, Hiroshi Kudo, Kengo Kawai, et al.
Diabetes|April 28, 2005
Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar ratsHiroaki Satoh, M T Audrey Nguyen, Maria Trujillo, et al.
Postgraduate Medicine|April 25, 2024
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetesYoshimasa Aso, Toshie Iijima, Teruo Jojima, et al.
Diabetology International|January 13, 2023
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetesMasato Kase, Toshie Iijima, Takafumi Niitani, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Clinics (Sao Paulo, Brazil)|November 14, 2025
Effects of pemafibrate (a selective PPAR-α agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLDKanako Kato, Teruo Jojima, Dai Tanuma, et al.
Journal of Diabetes and Its Complications|February 19, 2021
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosisMasaaki Sagara, Toshie Iijima, Masato Kase, et al.
International Journal of Clinical Practice|August 13, 2021
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitorsToshie Iijima, Soichiro Hosonuma, Hidetaka Kurai, et al.
Diabetology International|August 5, 2024
Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetesTomohisa Kunii, Isao Usui, Teruo Jojima, et al.
Journal of Medical Case Reports|April 21, 2019
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case reportTomohisa Kunii, Toshie Iijima, Teruo Jojima, et al.
Endocrine Journal|March 7, 2022
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intoleranceTeruo Jojima, Toshimitsu Shinzawa, Eriko Ohira, et al.
Biochemical and Biophysical Research Communications|January 2, 2010
Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver diseaseWei Zhang, Hiroshi Kudo, Kengo Kawai, et al.
Diabetes|April 28, 2005
Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar ratsHiroaki Satoh, M T Audrey Nguyen, Maria Trujillo, et al.
Postgraduate Medicine|April 25, 2024
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetesYoshimasa Aso, Toshie Iijima, Teruo Jojima, et al.
Diabetology International|January 13, 2023
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetesMasato Kase, Toshie Iijima, Takafumi Niitani, et al.
Pageof 9